60 related articles for article (PubMed ID: 15630487)
21. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation.
Dorfleutner A; Ruf W
Blood; 2003 Dec; 102(12):3998-4005. PubMed ID: 12920028
[TBL] [Abstract][Full Text] [Related]
22. Interference of activated factor VII in apoptosis of erytholeukemic K562 cells.
Kunzelman C; Toti F; Freyssinet JM; Meyer D
C R Biol; 2002 Nov; 325(11):1111-8. PubMed ID: 12506724
[TBL] [Abstract][Full Text] [Related]
23. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development.
Crosby JR; Tappan KA; Seifert RA; Bowen-Pope DF
Am J Pathol; 1999 May; 154(5):1315-21. PubMed ID: 10329583
[TBL] [Abstract][Full Text] [Related]
24. Endothelial-derived microvesicles promote pro-migratory cross-talk with smooth muscle cells by a mechanism requiring tissue factor and PAR2 activation.
Featherby SJ; Ettelaie C
Front Cardiovasc Med; 2024; 11():1365008. PubMed ID: 38966751
[TBL] [Abstract][Full Text] [Related]
25. Establishment of the active catalytic domain of human PDGFRbeta tyrosine kinase-based ELISA assay for inhibitor screening.
Zhang XH; Guo XN; Zhong L; Luo XM; Jiang HL; Lin LP; Ding J
Biochim Biophys Acta; 2007 Oct; 1770(10):1490-7. PubMed ID: 17719179
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.
Bromberg ME; Konigsberg WH; Madison JF; Pawashe A; Garen A
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8205-9. PubMed ID: 7667269
[TBL] [Abstract][Full Text] [Related]
27. Effect of PDGF-B aptamer on PDGFRβ/PDGF-B interaction: Molecular dynamics study.
Vu CQ; Rotkrua P; Soontornworajit B; Tantirungrotechai Y
J Mol Graph Model; 2018 Jun; 82():145-156. PubMed ID: 29738888
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor receptor beta is critical for zebrafish intersegmental vessel formation.
Wiens KM; Lee HL; Shimada H; Metcalf AE; Chao MY; Lien CL
PLoS One; 2010 Jun; 5(6):e11324. PubMed ID: 20593033
[TBL] [Abstract][Full Text] [Related]
29. Type H vessel/platelet-derived growth factor receptor β
Li J; Chen X; Ren L; Chen X; Wu T; Wang Y; Ren X; Cheng B; Xia J
Cell Prolif; 2023 Jul; 56(7):e13406. PubMed ID: 36694343
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the mechanisms of tissue factor-mediated evasion of tumour cells from cellular cytotoxicity.
Li C; Collier ME; Frentzou GA; Greenman J; Ettelaie C
Cancer Immunol Immunother; 2008 Sep; 57(9):1347-55. PubMed ID: 18297283
[TBL] [Abstract][Full Text] [Related]
31. In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method.
Jarvius M; Paulsson J; Weibrecht I; Leuchowius KJ; Andersson AC; Wählby C; Gullberg M; Botling J; Sjöblom T; Markova B; Ostman A; Landegren U; Söderberg O
Mol Cell Proteomics; 2007 Sep; 6(9):1500-9. PubMed ID: 17565975
[TBL] [Abstract][Full Text] [Related]
32. Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling.
Hosaka K; Yang Y; Nakamura M; Andersson P; Yang X; Zhang Y; Seki T; Scherzer M; Dubey O; Wang X; Cao Y
Cell Discov; 2018; 4():3. PubMed ID: 29423271
[TBL] [Abstract][Full Text] [Related]
33. Tumour-expressed tissue factor inhibits cellular cytotoxicity.
Li C; Colman LM; Collier ME; Dyer CE; Greenman J; Ettelaie C
Cancer Immunol Immunother; 2006 Nov; 55(11):1301-8. PubMed ID: 16453151
[TBL] [Abstract][Full Text] [Related]
34. Potential Role of PDGFRβ-Associated THBS4 in Colorectal Cancer Development.
Kim MS; Choi HS; Wu M; Myung J; Kim EJ; Kim YS; Ro S; Ha SE; Bartlett A; Wei L; Ryu HS; Choi SC; Park WC; Kim KY; Lee MY
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899998
[TBL] [Abstract][Full Text] [Related]
35. In silico tissue factor analysis: a bit-to-bit comparison.
Peppelenbosch MP; Versteeg HH; Spek CA
Thromb Haemost; 2003 Mar; 89(3):592-3. PubMed ID: 12624646
[No Abstract] [Full Text] [Related]
36. Tissue factor-dependent signaling in tumor biology.
Ruf W
Pathophysiol Haemost Thromb; 2003; 33 Suppl 1():28-30. PubMed ID: 12954997
[No Abstract] [Full Text] [Related]
37. Erratum: Specific targeting of PDGFRβ in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression: Erratum.
Tsioumpekou M; Cunha SI; Ma H; Åhgren A; Cedervall J; Olsson AK; Heldin CH; Lennartsson J
Theranostics; 2020; 10(16):7406-7408. PubMed ID: 32642001
[TBL] [Abstract][Full Text] [Related]
38. New helpers in TF-dependent migration.
Versteeg HH; Ruf W
J Thromb Haemost; 2013 Oct; 11(10):1877-9. PubMed ID: 23941045
[No Abstract] [Full Text] [Related]
39. PAE under the AEI thesis: a response.
Murray CM; Crother BI
Cladistics; 2014 Jun; 30(3):234-235. PubMed ID: 34784693
[No Abstract] [Full Text] [Related]
40. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
